- Home
- LEGN vs PARA Comparison
LEGN vs PARA Comparison
Compare LEGN & PARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- PARA
- Stock Information
- Founded
- LEGN 2014
- PARA 1986
- Country
- LEGN United States
- PARA United States
- Employees
- LEGN N/A
- PARA N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- PARA Broadcasting
- Sector
- LEGN Health Care
- PARA Industrials
- Exchange
- LEGN Nasdaq
- PARA Nasdaq
- Market Cap
- LEGN 7.0B
- PARA 7.9B
- IPO Year
- LEGN 2020
- PARA N/A
- Fundamental
- Price
- LEGN $27.69
- PARA $11.85
- Analyst Decision
- LEGN Strong Buy
- PARA Sell
- Analyst Count
- LEGN 13
- PARA 13
- Target Price
- LEGN $75.67
- PARA $11.42
- AVG Volume (30 Days)
- LEGN 1.5M
- PARA 7.4M
- Earning Date
- LEGN 05-13-2025
- PARA 05-08-2025
- Dividend Yield
- LEGN N/A
- PARA 1.68%
- EPS Growth
- LEGN N/A
- PARA N/A
- EPS
- LEGN N/A
- PARA N/A
- Revenue
- LEGN $728,303,000.00
- PARA $28,720,000,000.00
- Revenue This Year
- LEGN $65.96
- PARA $0.09
- Revenue Next Year
- LEGN $52.55
- PARA $1.13
- P/E Ratio
- LEGN N/A
- PARA N/A
- Revenue Growth
- LEGN 112.46
- PARA N/A
- 52 Week Low
- LEGN $29.27
- PARA $9.54
- 52 Week High
- LEGN $60.87
- PARA $13.40
- Technical
- Relative Strength Index (RSI)
- LEGN 29.04
- PARA 56.40
- Support Level
- LEGN $30.25
- PARA $11.74
- Resistance Level
- LEGN $33.30
- PARA $12.08
- Average True Range (ATR)
- LEGN 1.78
- PARA 0.25
- MACD
- LEGN -0.53
- PARA 0.04
- Stochastic Oscillator
- LEGN 3.10
- PARA 69.39
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About PARA Paramount Global Class B
Paramount Global operates in three global business segments: TV media, filmed entertainment, and direct to consumer. The TV media business includes television production studios and various broadcast and cable networks, including CBS, 15 owned CBS affiliates, Paramount, Nickelodeon, MTV, BET, and VH1. Filmed entertainment consists multiple film studios, most importantly Paramount Pictures. The film studios produce and distribute movies that they license to movie theaters and other media outlets. Direct to consumer includes the Paramount+, Pluto TV, and BET+ streaming services. Much of the content on Paramount's streaming platforms is created by the production studios housed within the firm's other two business segments.